Trophoblastic Lesions ■ The WHO classification of gestational trophoblastic disease (GTD) and the TNM and FIGO classifications of gestational trophoblastic tumors are presented in Tables 10.1–10.4 . Table 10.1 Types…
▪ Various non-neoplastic endometrial lesions, as well as normal and artifactual findings, can be problematic for the pathologist, especially their distinction from precancerous endometrial lesions and carcinomas. ▪ Table 7.1…
Appendix 1: Ovarian Tumors With Mucinous Epithelium Primary Tumors ■ Surface epithelial tumors • Mucinous cystic tumors of intestinal and endocervical-like type • Surface epithelial tumors of mixed cell type…
Precursors Classification ▪ The classifications used for precursors of cervical invasive squamous cell carcinoma (ISqCC), in order of their historical development, are: (1) dysplasia/carcinoma in situ (CIS); (2) cervical intraepithelial…
Tumor-Like Lesions Metaplasias and Ectopias Squamous Metaplasia ( Figs. 4.1 – 4.2 ) ■ This normal process within the transitional zone of postpubertal women results in the replacement of endocervical…
Tumor-Like and Inflammatory Lesions Condyloma Acuminatum ▪ These resemble their vulvar counterparts ( Chapter 1 ) except for a more frequent occurrence of flat condylomas and those with a ‘spiked’…
Viral Infections Human Papillomavirus (Hpv) (Including Condyloma Acuminatum) Clinical and gross features ( Fig. 1.1 ) ▪ Sexually transmitted HPV (usually low-risk types, especially HPV 6 and 11) is the…
Squamous Cell Carcinoma and Its Precursors Vulvar Intraepithelial Neoplasia (VIN) Terminology ■ The main types of VIN – usual VIN (uVIN) and differentiated VIN (dVIN) – each have distinctive clinical…
Outline Overview How Do Medications to Treat Opioid Use Disorder Work? How Effective Are Medications to Treat Opioid Use Disorder? What Are Misconceptions About Maintenance Treatment? What Is the Treatment…
Outline Foreword Executive Summary Introduction Overall Key Messages Content Overview Part 1: Introduction to Medications or Opioid Use Disorder Treatment Part 2: Addressing Opioid Use Disorder in General Medical Settings…
